Pertussis Completed Phase 3 Trials for Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) (DB10584)

Also known as: Whooping cough due to Bordetella pertussis / Whooping Cough / Whooping cough due to bordetella pertussis (B. pertussis)

IndicationStatusPhase
DBCOND0014696 (Pertussis)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00255047Safety and Immune Response of Different Pediatric Combination Vaccines.Prevention
NCT00258895Safety and Immunogenicity of DAPTACEL® as 5th Dose in Children 4 to 6 Years Old After 4 Doses of Pentacel™ or DAPTACEL®Prevention
NCT01346293Study of DTap-IPV Compared to DAPTACEL® and IPOL® as the 5th Dose in Children 4 to 6 Years of AgePrevention
NCT02089347Study of SP306 Given Intramuscularly Compared to DT BIK® Given Subcutaneously in Japanese Adolescents 11 - 12 Years OldPrevention